UCB Transplant of Inherited Metabolic Diseases With Administration of Intrathecal UCB Derived Oligodendrocyte-Like Cells

计划入组 40 人 · 首次发布于 2014 年 10 月 2 日

UCB Therapy in Acquired Brain Injury

计划入组 3 人 · 首次发布于 2013 年 6 月 25 日

UCB Cimzia Pregnancy Follow-up Study

计划入组 1 人 · 首次发布于 2016 年 5 月 17 日

UCB-35440

UCB-1017471

UCB-6330

UCB Biosciences, Inc.

United States

UCB BioSciences GmbH

Germany

UCB CELLTECH

United Kingdom

Eczema Drug Development Pipeline Surges with 100+ Companies Advancing Novel Therapies

EU Pharmaceutical Reforms Reshape Rare Disease and Pediatric Drug Development Strategies

Roche Terminates Alzheimer's Partnership with UCB, Returns Rights to Bepranemab